In a French cohort, the incidence of all-cause mortality among those who received a first dose of an mRNA COVID vaccine was 0 ...

Members of the Advisory Committee on Immunization Practices, from left, Vicky Pebsworth, Dr. Joseph Hibbeln, and Dr. Raymond ...

FDA commissioners lambasted the CBER head’s plans to use a probe into COVID vaccine safety to upend longstanding regulatory ...

Objectives Growing evidence suggests that vaccines targeting respiratory pathogens have non-specific and broader effects. We aimed to investigate the non-specific effects of respiratory vaccines on ...

A new WHO report reveals that while measles deaths have fallen by 88 per cent since 2000, global infections have surged to 1.1 crore in 2024—higher than pre-pandemic levels ...

For decades, health-related statements by major professional health associations such as the American Medical Association (AMA) agreed with those of the Centers for Disease Control and Prevention (CDC ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Influenza prevention with the cell-based quadrivalent vaccine (QIVc) was superior to the egg-based vaccine (QIVe) during the US 2022–2023 flu season.

Bernstein warned in a note Tuesday that “shock waves are expected at the ACIP meeting this week,” citing a series of unusual developments that could have implications for Merck, Pfizer and Moderna.

According to DataM Intelligence. The Prescription Drugs Market Size, valued at a substantial US$1240.33 billion in 2024, is projected to surge to US$2151.63 billion by 2032. This robust expansion ...

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down by -0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down ...

This report provides useful evidence that EABR mRNA is at least as effective as standard S mRNA vaccines for the SARS-CoV-2 booster vaccine. Although the methodology and the experimental approaches ...